CGON(CGON)
CGON
ANALYST COVERAGE10 analysts
BUY
▲ +22.5%upside to target
L $70.00
Med $82.00consensus
H $93.00PRICE
Prev Close
69.54
Open
70.00
Day Range66.47 – 70.00
66.47
70.00
52W Range23.65 – 75.50
23.65
75.50
83% of range
VOLUME & SIZE
Avg Volume
1.2M
FUNDAMENTALS
P/E Ratio
-28.6x
Not profitable
EPS (TTM)
—
Div Yield
No dividend
TECHNICAL
RSI (14)
89
Overbought
Upcoming Events
EEarnings Report
Tomorrow
May 19
DEx-Dividend
In 88 days
Aug 14
PDividend Pay
In 91 days
Aug 17
Key MetricsTTM
Market Cap$5.90B
Revenue TTM$5.07M
Net Income TTM-$186.75M
Free Cash Flow-$160.43M
Gross Margin-47.0%
Operating Margin-4239.0%
Net Margin-3682.6%
Return on Equity-23.3%
Return on Assets-16.4%
Debt / Equity0.01
Current Ratio31.30
EPS TTM$-2.21
CGON News
About
No description available.
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Bing KungVice President of Corporate Development
Vijay KasturiChief Medical Officer
Ambaw BelletePresident & Chief Operating Officer
Arthur KuanChairman & Chief Executive Officer
Swapnil BhargavaChief Technical Officer
Amy SteeleVice President of Finance & Administration
Sarah ConnorsVice President of Communications & Patient Advocacy
James DeToreChief Financial Officer
Joshua F. PattersonGeneral Counsel, Chief Compliance Officer & Secretary